mRNA flu shots have officially arrived. On August 5, the U.S. Food and Drug Administration approved the first influenza vaccine that uses the same technology underpinning COVID-19 shots.

The U.S. Food and Drug Administration has approved Moderna's (MRNA.O) flu vaccine for people aged 50 and older, the company said on Wednesday, marking the first approval of a messenger RNA-based vacci...

“The FDA approval of mFLUSIVA, our fourth approved product in the United States and the first mRNA-based flu vaccine, demonstrates the continued strength and versatility of our mRNA platform,” said St...